Susan Hasty, Publisher
Table of Contents . . . February 5th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Head and Neck Cancer - New mutant FasL gene therapy controls nasopharyngeal carcinoma growth
Cell Biology - RNA interference of hypoxia inducible factor lessens its impact on cell growth
Collaborations - Genetics company signs manufacturing deal for VEGF-2
Collaborations - RNA interference to be used in study of obesity and diabetes
Endocrinology - Gut peptides modulate pancreatic secretions
Gastroenterology - Nuclear factor kappaB inhibition impairs pancreatic cancer angiogenesis
Gene Delivery - U.S. patents issued for gene delivery technologies
Gene Replacement - Ex vivo gene therapy rectifies Niemann-Pick disease in animal models
Gene Suppression - Telomerase is a major regulator of leukemia cell growth
Gene Transfer - Episomal constructs drive long-term integration under selective conditions
Genetic Analysis - New highly scalable GenomeLab system launched
Hematology - Transduced stem cells hold the potential for correcting sickle cell disease
Immunology - Adoptive immunity fosters gene expression after cell transfection
Lipid Studies - Fatty acids alter monolayer integrity and iron transport in Caco-2 cells
Malaria Vaccine - DNA vaccine elicits strong immune response against malaria sporozoites
Oncology - BAG-1 uses a variety of pathways to generate chemoresistance
Osteoporosis - Gene affecting bone mass identified as potential human therapeutic target
Patents - Vaccine company gets broad patent coverage for its core technology platform
Protease Inhibitor - Shipments begin of plant-produced recombinant aprotinin product
Pulmonary Medicine - Gene transfer improves lung liquid clearance in ventilation models
Respiratory Syncytial Virus - Vaccine elicits immune response against respiratory syncytial virus
Severe Combined Immune Deficiency - Unusual leukemia caused by rare combination of genes
Cystic Fibrosis - Serial doses of aerosolized viral vector do well in nonhuman primates
Sickle-Cell Disease - Clinical compound rPSGL-Ig licensed for development and commercialization
Spinal Muscular Atrophy - FSMA, genetics company, open screening capabilities to third-party compounds
Stem-Cell Research - Acute myeloid leukemia fusion proteins deregulate maintenance and repair genes
Tumor Suppression - A recombinant fragment of thrombospondin-2 halts VEGF-induced tumor growth
Vector Development - Deoxyribonuclease II cripples nonviral transfection
Virology - New techniques purify adeno-associated virus type 5 with less work
Weight Loss - Study suggests dieters shouldn't give up - slimming hormone waits to be unleashed
Endocrinology - Arginine-vasopressin offers persistent correction of diabetes insipidus
Gene Transfer - The novel peptide NLSV40 encourages DNA accumulation after transfection
Neurology - Fibroblast growth factor-2 gene delivery regenerates adult axon growth
Adenovirus - Analysis of CD8+ T-cell response after adenovirus vaccination presented
Antimicrobial Resistance - ABC multidrug efflux pump identified in Enterococcus faecalis
Botulinum Neurotoxin - $1.1M contract awarded to study counter-bioterrorism vaccine
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.